Roberton James Stevenson Sells 109 Shares of Addus HomeCare Co. (NASDAQ:ADUS) Stock

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) EVP Roberton James Stevenson sold 109 shares of the firm’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $103.93, for a total transaction of $11,328.37. Following the transaction, the executive vice president now owns 10,434 shares of the company’s stock, valued at approximately $1,084,405.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $102.59 on Thursday. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 2.03 and a beta of 0.96. The company has a 50 day moving average of $95.32 and a 200-day moving average of $90.20. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. Addus HomeCare Co. has a 1-year low of $77.30 and a 1-year high of $114.97.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, February 26th. The company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.17. The company had revenue of $276.35 million during the quarter, compared to analyst estimates of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. On average, equities analysts forecast that Addus HomeCare Co. will post 4.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. TheStreet upgraded shares of Addus HomeCare from a “c+” rating to a “b-” rating in a research note on Friday, December 22nd. TD Cowen assumed coverage on shares of Addus HomeCare in a research note on Tuesday, December 12th. They set an “outperform” rating and a $105.00 price target for the company. Oppenheimer restated an “outperform” rating and set a $118.00 price target on shares of Addus HomeCare in a research note on Tuesday, March 26th. Finally, Barclays started coverage on shares of Addus HomeCare in a report on Wednesday, March 6th. They set an “equal weight” rating and a $88.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $103.83.

Read Our Latest Stock Analysis on ADUS

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently modified their holdings of the stock. Principal Securities Inc. acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $26,000. Macquarie Group Ltd. increased its holdings in shares of Addus HomeCare by 84.0% in the fourth quarter. Macquarie Group Ltd. now owns 287 shares of the company’s stock valued at $29,000 after purchasing an additional 131 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $30,000. BluePath Capital Management LLC acquired a new stake in shares of Addus HomeCare in the third quarter valued at approximately $31,000. Finally, GAMMA Investing LLC acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.